Literature DB >> 9004442

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

W E Beyer1, A M Palache, M J Sprenger, E Hendriksen, J J Tukker, R Darioli, G L van der Water, N Masurel, A D Osterhaus.   

Abstract

Three cohort studies in adults were performed during the period from 1986 to 1989. Eight hundred and eighty-four subjects were, one or more times, immunized with influenza vaccines, and pre- and post-vaccination antibody titres were determined by hemagglutination inhibition tests. One thousand and one hundred and nineteen vaccination events in 681 subjects could be analysed by a comparison, per trial and per influenza (sub)type, between groups with and without influenza vaccination in previous years. Effect size, odds ratio and protection rate difference, were used as effect measures. Subjects with previous vaccination showed higher pre-vaccination antibody than those without. The average change of the post-vaccination proportion of subjects with high antibody titre value to previous vaccination, was +9.4% (95% CI: +5.3 to 13.6%) for A-H3N2 vaccine components, -2.1% (-8.1 to 3.9%, not significant) for A-H1N1 and -10.6% (-16.5% to -4.8%) for B. In a linear regression model, pre-vaccination titres and the status of previous vaccination were identified as factors significantly influencing post-vaccination titres. These findings are discussed in the context of a short review of the literature. It is concluded that the status of previous vaccination should always be addressed as an independent factor in serological vaccination studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004442     DOI: 10.1016/s0264-410x(96)00058-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  44 in total

1.  Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

Authors:  T Menegon; V Baldo; C Bonello; D Dalla Costa; A Di Tommaso; R Trivello
Journal:  Eur J Epidemiol       Date:  1999-07       Impact factor: 8.082

2.  Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.

Authors:  Lisa M Christian; Chloe Beverly; Amanda M Mitchell; Erik Karlsson; Kyle Porter; Stacey Schultz-Cherry; Octavio Ramilo
Journal:  Vaccine       Date:  2017-08-01       Impact factor: 3.641

3.  Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

Authors:  Davide Bedognetti; Gabriele Zoppoli; Carlotta Massucco; Elisa Zanardi; Simonetta Zupo; Andrea Bruzzone; Mario Roberto Sertoli; Enrico Balleari; Omar Racchi; Marco Messina; Graziano Caltabiano; Giancarlo Icardi; Paolo Durando; Francesco M Marincola; Francesco Boccardo; Manlio Ferrarini; Filippo Ansaldi; Andrea De Maria
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

4.  Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.

Authors:  R W Grant; R A Mariani; V J Vieira; M Fleshner; T P Smith; K T Keylock; T W Lowder; E McAuley; L Hu; K Chapman-Novakofski; J A Woods
Journal:  Brain Behav Immun       Date:  2008-03-04       Impact factor: 7.217

5.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

6.  Immune response to influenza vaccination in children with cancer.

Authors:  Dimitrios Doganis; Athanasia Kafasi; Helen Dana; Nikolaos Spanakis; Margarita Baka; Apostolos Pourtsidis; Triantafyllia Sdogou; Artemis Vintila; Vaia Rafailidou; Panagiota Chantzi; Marina Servitzoglou; Despina Bouhoutsou; Maria Varvoutsi; Helen Kosmidis; Maria Tsolia
Journal:  Hum Vaccin Immunother       Date:  2018-06-08       Impact factor: 3.452

7.  Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy.

Authors:  Zhenwu Luo; Elizabeth Ogunrinde; Min Li; Lumin Zhang; Lisa Martin; Zejun Zhou; Zhiliang Hu; Tao Zhang; Zhen Li; Jiafeng Zhang; Bin Su; Tong Zhang; Hao Wu; Lei Ma; Guoyang Liao; Allison Ross Eckard; Maria Anna Julia Westerink; Sonya L Heath; Wei Jiang
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

8.  Influenza vaccine effectiveness in the community and the household.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Benjamin J Cowling; Mark G Thompson; David K Shay; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-02-14       Impact factor: 9.079

9.  Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.

Authors:  Ted M Ross; Chyongchiou Jeng Lin; Mary Patricia Nowalk; Hsin-Hui Huang; Sarah M Spencer; David K Shay; Suryaprakash Sambhara; Maria E Sundaram; Thomas Friedrich; Sandy Sauereisen; Chalise E Bloom; Richard K Zimmerman
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

10.  Evaluation of vaccine-induced antibody responses: impact of new technologies.

Authors:  Daniel J Zaccaro; Diane K Wagener; Carol C Whisnant; Herman F Staats
Journal:  Vaccine       Date:  2013-04-11       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.